Dina Fine Maron, Editor of Health & Medicine at Scientific American, joins Cheddar to discuss some of the biggest changes to science regulations we'll see in 2018. From food labels to nonaddictive cigarettes, people need to be aware of what might affect their everyday lives.
A revamped nutrition label was slated to debut in July of 2018, however the Trump administration is giving companies a longer window. Major companies now have until 2020 and smaller companies have until 2021. The new labels will have more detail on added sugar and calorie count. However, critics say the delay could be a major blow to the public's health.
Plus, the U.S. Food and Drug Administration aims to create a nonaddictive cigarette with lower nicotine levels. It hopes this will help smokers quit. However, the agency opened up the conversation to the public for input which will ellicit some strong views from the tobacco industry.
Blame geography for the U.S. getting hit by stronger, costlier, more varied and frequent extreme weather than anywhere on the planet, several experts said. But that's only part of it.
Residents across a wide swath of the U.S. raced Sunday to assess the destruction from fierce storms that spawned possibly dozens of tornadoes from the South and the Midwest into the Northeast.
The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time a opioid treatment drug will be available without a prescription.
Millions of Americans could lose access to Medicaid on April 1, and Joe Dunn, senior vice president of public policy at the National Association of Community Health Centers, joined Cheddar News' anchor Shannon LaNier to discuss what this means for public health.
One third of Americans don't have access to primary care providers in their communities, according to a study from the National Association of Community Health Centers published last month.
Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report.
